BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

555 related articles for article (PubMed ID: 32476795)

  • 1. Pancreatic neuroendocrine tumors: A review of serum biomarkers, staging, and management.
    Ma ZY; Gong YF; Zhuang HK; Zhou ZX; Huang SZ; Zou YP; Huang BW; Sun ZH; Zhang CZ; Tang YQ; Hou BH
    World J Gastroenterol; 2020 May; 26(19):2305-2322. PubMed ID: 32476795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-functional neuroendocrine tumors of the pancreas: Advances in diagnosis and management.
    Cloyd JM; Poultsides GA
    World J Gastroenterol; 2015 Aug; 21(32):9512-25. PubMed ID: 26327759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgical management of pancreatic neuroendocrine tumors: an introduction.
    Hain E; Sindayigaya R; Fawaz J; Gharios J; Bouteloup G; Soyer P; Bertherat J; Prat F; Terris B; Coriat R; Gaujoux S
    Expert Rev Anticancer Ther; 2019 Dec; 19(12):1089-1100. PubMed ID: 31825691
    [No Abstract]   [Full Text] [Related]  

  • 4. Pancreatic neuroendocrine neoplasms.
    Hörsch D; Bert T; Schrader J; Hommann M; Kaemmerer D; Petrovitch A; Zaknun J; Baum RP
    Minerva Gastroenterol Dietol; 2012 Dec; 58(4):401-26. PubMed ID: 23207615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Cytotoxic Chemotherapy in Advanced Pancreatic Neuroendocrine Tumors.
    Krug S; Gress TM; Michl P; Rinke A
    Digestion; 2017; 96(2):67-75. PubMed ID: 28728148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroendocrine tumors of the pancreas.
    Milan SA; Yeo CJ
    Curr Opin Oncol; 2012 Jan; 24(1):46-55. PubMed ID: 22080942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroendocrine pancreatic tumors: guidelines for management and update.
    Burns WR; Edil BH
    Curr Treat Options Oncol; 2012 Mar; 13(1):24-34. PubMed ID: 22198808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent Updates in the Management of Advanced Pancreatic Neuroendocrine Tumors.
    Cho CM
    Korean J Gastroenterol; 2019 Mar; 73(3):124-131. PubMed ID: 31013555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pancreatic neuroendocrine tumors.
    Perri G; Prakash LR; Katz MHG
    Curr Opin Gastroenterol; 2019 Sep; 35(5):468-477. PubMed ID: 31306159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastroenteropancreatic Neuroendocrine Tumors.
    Cives M; Strosberg JR
    CA Cancer J Clin; 2018 Nov; 68(6):471-487. PubMed ID: 30295930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic neuroendocrine tumors: Nosography, management and treatment.
    Orditura M; Petrillo A; Ventriglia J; Diana A; Laterza MM; Fabozzi A; Savastano B; Franzese E; Conzo G; Santini L; Ciardiello F; De Vita F
    Int J Surg; 2016 Apr; 28 Suppl 1():S156-62. PubMed ID: 26708853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Baseline chromogranin A and its dynamics are prognostic markers in gastroenteropancreatic neuroendocrine tumors.
    Rogowski W; Wachuła E; Lewczuk A; Kolasińska-Ćwikła A; Iżycka-Świeszewska E; Sulżyc-Bielicka V; Ćwikła JB
    Future Oncol; 2017 May; 13(12):1069-1079. PubMed ID: 28095720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastroenteropancreatic neuroendocrine tumours: an overview.
    Davies L; Weickert MO
    Br J Nurs; 2016 Feb 25-Mar 9; 25(4):S12-5. PubMed ID: 26911175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An overview of pancreatic neuroendocrine tumours.
    Burgess A
    Nurs Stand; 2008 Oct 29-Nov 4; 23(8):35-40. PubMed ID: 18986079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroendocrine tumors of the pancreas.
    Ehehalt F; Saeger HD; Schmidt CM; Grützmann R
    Oncologist; 2009 May; 14(5):456-67. PubMed ID: 19411317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of pancreatic neuroendocrine tumors.
    Dickson PV; Behrman SW
    Surg Clin North Am; 2013 Jun; 93(3):675-91. PubMed ID: 23632152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic Therapies for Metastatic Pancreatic Neuroendocrine Tumors.
    Hauser H; Gerson DS; Reidy-Lagunes D; Raj N
    Curr Treat Options Oncol; 2019 Nov; 20(12):87. PubMed ID: 31776785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic impact of the cumulative dose and dose intensity of everolimus in patients with pancreatic neuroendocrine tumors.
    Berardi R; Torniai M; Pusceddu S; Spada F; Ibrahim T; Brizzi MP; Antonuzzo L; Ferolla P; Panzuto F; Silvestris N; Partelli S; Ferretti B; Freddari F; Gucciardino C; Testa E; Concas L; Murgioni S; Bongiovanni A; Zichi C; Riva N; Rinzivillo M; Brunetti O; Giustini L; Di Costanzo F; Delle Fave G; Fazio N; De Braud F; Falconi M; Cascinu S
    Cancer Med; 2017 Jul; 6(7):1493-1499. PubMed ID: 28547856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An update on the management of pancreatic neuroendocrine tumors.
    Gao L; Natov NS; Daly KP; Masud F; Chaudhry S; Sterling MJ; Saif MW
    Anticancer Drugs; 2018 Aug; 29(7):597-612. PubMed ID: 29782352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical Management of Pancreatic Neuroendocrine Tumors.
    Clancy TE
    Hematol Oncol Clin North Am; 2016 Feb; 30(1):103-18. PubMed ID: 26614371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.